Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash and cash equivalents	$ 1,820,127	$ 927,468
Cash, restricted	0	507,517
Accounts receivable, net	5,301,528	5,300,190
Inventory, net	2,893,036	3,473,604
Other current assets	63,505	144,143
Asset held for sale - discontinued operations	0	6,144,793
Current assets - discontinued operations	20,929	281,699
Total current assets	10,099,125	16,779,414
Property and equipment, net	1,214,231	1,273,310
Right of use assets - operating leases, net	373,416	512,389
Right of use assets - finance leases, net	16,155	205,340
Amortizable intangible assets, net	294,902	338,059
Indefinite-lived intangible assets	217,000	217,000
Other noncurrent assets	40,000	40,000
Noncurrent assets - discontinued operations	0	215,509
Total assets	12,254,829	19,581,021
Current liabilities
Accounts payable	2,013,048	2,456,429
Accrued payroll	219,120	79,559
Accrued liabilities	446,440	499,811
Accrued separation costs - related parties, current portion	425,376	109,236
Stock appreciation rights liability	0	16,143
Notes payable, current portion	68,032	66,026
Lease liability - operating leases, current	302,620	285,534
Lease liability - finance leases, current	0	48,866
Current liabilities - discontinued operations	27,330	8,877,624
Total current liabilities	3,501,966	12,439,228
Note payable non-current	182,242	216,947
Accrued separation costs - related parties, non-current	0	400,000
Lease liability - operating leases, non-current	81,013	234,963
Lease liability - finance leases, non-current	0	52,683
Total liabilities	3,765,221	13,343,821
Commitments & contingencies (see note 18)	0	0
Stockholders’ equity
Common stock: $0.0001 par value; 500,000,000 shares authorized; 57,493,776 shares issued, and 54,649,479 shares outstanding at June 30, 2026 and December 31, 2025, respectively	5,746	5,746
Additional paid-in capital	45,695,650	45,647,902
Treasury stock: 2,644,297 shares outstanding at June 30, 2026 and December 31, 2025	(1,141,372)	(1,141,372)
Accumulated deficit	(36,070,416)	(38,275,076)
Total stockholders’ equity	8,489,608	6,237,200
Total liabilities and stockholders’ equity	$ 12,254,829	$ 19,581,021

Liability arising from stock appreciation rights.

No definition available.

Name:	ivfh_StockAppreciationRightsLiability
Namespace Prefix:	ivfh_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).